摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-amino-4-hydroxyphenyl)-2-(4'-hydroxyphenyl)propane | 233756-95-1

中文名称
——
中文别名
——
英文名称
2-(3-amino-4-hydroxyphenyl)-2-(4'-hydroxyphenyl)propane
英文别名
2-Amino-4-[1-(4-hydroxyphenyl)-1-methylethyl]phenol;2-amino-4-[2-(4-hydroxyphenyl)propan-2-yl]phenol
2-(3-amino-4-hydroxyphenyl)-2-(4'-hydroxyphenyl)propane化学式
CAS
233756-95-1
化学式
C15H17NO2
mdl
——
分子量
243.305
InChiKey
STKLELJBYIGLSM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    66.5
  • 氢给体数:
    3
  • 氢受体数:
    3

文献信息

  • Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
    申请人:Terkeltaub Robert
    公开号:US20070021496A1
    公开(公告)日:2007-01-25
    The present invention relates to improved diagnostic methods for early detection of a risk for developing an arthritic disorder in humans, and screening assays for therapeutic agents useful in the treatment of arthritic disorders, by comparing the levels of one or more indicators of altered mitochondrial function. Indicators of altered mitochondrial function include enzymes such as mitochondrial enzymes and ATP biosynthesis factors. Other indicators of altered mitochondrial function include mitochondrial mass, mitochondrial number and mitochondrial DNA content, cellular responses to elevated intracellular calcium and to apoptogens, and free radical production. Methods of treating, and of stratifying, human patients as such methods relate to disclosed indicators of altered mitchondrial function are also provided.
    本发明涉及改进的诊断方法,用于早期检测人类发展关节炎性疾病风险,并通过比较改变的线粒体功能指标的平,筛选用于治疗关节炎性疾病的治疗剂的检测方法。改变的线粒体功能指标包括线粒体酶和ATP合成因子等酶。其他改变的线粒体功能指标包括线粒体质量、线粒体数量、线粒体DNA含量、细胞对细胞内钙离子和凋亡原的反应,以及自由基产生。还提供了与披露的改变的线粒体功能指标相关的治疗和分层人类患者的方法。
  • Antioxidant and bisaminophenol derivative
    申请人:Shiraki Yasushi
    公开号:US20060208227A1
    公开(公告)日:2006-09-21
    The present invention provides antioxidants made of an aromatic hydroxyamine derivative having a structure represented by the general formula (I): wherein R 1 , R 2 and R 3 are each independently a hydrogen atom or an alkyl group having 1 to 20 carbon atoms; X is a hydrogen atom or an OH group; Y is a hydrogen atom or an NHR 1 group; A is a direct bond, —O—, —NH—, —SO 2 —, —CH 2 — or —C(CH 3 ) 2 —, and when an OH group and an NHR 1 group are introduced to a unilateral benzene ring, these groups are respectively bonded to adjacent positions of the benzene ring; and n is 0 or 1 with the proviso that when n is 0, R 1 is not a hydrogen atom, as well as bisaminophenol derivatives represented by the above general formula (I) wherein n is 1; R 2 and R 3 are each a hydrogen atom; X is an OH group; Y is an NHR 1 group; A is —C(CH 3 ) 2 —; and R 1 is isopropyl, isobutyl or isohexyl. The aromatic hydroxyamine derivatives having a structure represented by the general formula (I), in particular, the bisaminophenol derivatives as novel substances, exhibit an excellent oxidation-inhibiting property, and are usable as antioxidants or polymerization inhibitors.
    本发明提供一种抗氧化剂,其由一种芳香族羟胺生物制成,其结构由通式(I)表示: 其中,R1、R2和R3分别独立地为氢原子或具有1到20个碳原子的烷基;X为氢原子或OH基团;Y为氢原子或NHR1基团;A为直接键,-O-,-NH-,-SO2-,-CH2-或-C(CH3)2-,当OH基团和NHR1基团被引入单侧苯环时,这些基团分别与苯环的相邻位置键合;n为0或1,但当n为0时,R1不是氢原子,以及由上述通式(I)表示的双生物,其中n为1;R2和R3均为氢原子;X为OH基团;Y为NHR1基团;A为-C( )2-;R1为异丙基、异丁基或异己基。具有通式(I)表示的芳香族羟胺生物,特别是作为新物质的双生物,表现出优异的抗氧化性能,并可用作抗氧化剂或聚合物抑制剂
  • ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE
    申请人:SHIRAKI Yasushi
    公开号:US20080161608A1
    公开(公告)日:2008-07-03
    The present invention provides antioxidants made of an aromatic hydroxyamine derivative having a structure represented by the general formula (I): wherein R 1 , R 2 and R 3 are each independently a hydrogen atom or an alkyl group having 1 to 20 carbon atoms; X is a hydrogen atom or an OH group; Y is a hydrogen atom or an NHR 1 group; A is a direct bond, —O—, —NH—, —SO 2 —, —CH 2 — or —C(CH 3 ) 2 —, and when an OH group and an NHR 1 group are introduced to a unilateral benzene ring, these groups are respectively bonded to adjacent positions of the benzene ring; and n is 0 or 1 with the proviso that when n is 0, R 1 is not a hydrogen atom, as well as bisaminophenol derivatives represented by the above general formula (I) wherein n is 1; R 2 and R 3 are each a hydrogen atom; X is an OH group; Y is an NHR 1 group; A is —C(CH 3 ) 2 —; and R 1 is isopropyl, isobutyl or isohexyl. The aromatic hydroxyamine derivatives having a structure represented by the general formula (I), in particular, the bisaminophenol derivatives as novel substances, exhibit an excellent oxidation-inhibiting property, and are usable as antioxidants or polymerization inhibitors.
    本发明提供了一种芳香族羟胺生物制备的抗氧化剂,其结构由通式(I)表示:其中,R1、R2和R3各自独立地是氢原子或具有1到20个碳原子的烷基基团;X是氢原子或羟基(OH)基团;Y是氢原子或NHR1基团;A是直接键、—O—、—NH—、—SO2—、—CH2—或—C(CH3)2—,当在一个单侧苯环上引入OH基团和NHR1基团时,这些基团分别与苯环的相邻位置结合;n为0或1,但当n为0时,R1不是氢原子。此外,本发明还提供了通式(I)所表示的双生物,其中n为1;R2和R3均为氢原子;X为羟基(OH)基团;Y为NHR1基团;A为—C( )2—;而R1为异丙基、异丁基或异己基。具有通式(I)所表示的芳香族羟胺生物,尤其是作为新化合物的双生物,表现出优异的抗氧化性能,可用作抗氧化剂或聚合抑制剂
  • PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES
    申请人:Song Chengqian
    公开号:US20120035307A1
    公开(公告)日:2012-02-09
    The present invention generally relates to a process for preparing stabilized polymeric systems with excellent light, thermal and oxidation stability using a redox formulation containing an oxidizing agent, a reducing agent, and/or nano-additives, and the polymer articles made therefrom.
  • METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES
    申请人:Song Chengqian
    公开号:US20120035315A1
    公开(公告)日:2012-02-09
    The present invention generally relates to a process for preparing stabilized polymeric systems with excellent light, thermal and oxidation stability using an active, peroxide containing polymer oxidizing agents, amine-containing reducing agents, and/or nano-additives, and the polymer articles made therefrom.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫